Immunization and Vaccine-Preventable Disease
Immunization is the deliberate induction of protective immunity against an infectious agent, most often by administering a vaccine. This area covers the practice of vaccination across the life course and the diseases it is designed to prevent, treating vaccines both as a tool of individual protection and as one of the most effective interventions in population health.
Definition
Immunization is the process of inducing or providing immunity to an infectious disease, typically through active immunization with a vaccine that stimulates the recipient's own adaptive immune response to generate protective, often durable, memory. A vaccine-preventable disease is an infectious disease for which a licensed vaccine exists that reduces the risk of infection, illness, or transmission.
Scope
The area orients the reader to active immunization as a preventive-medicine practice: how vaccination schedules are organised for children, adolescents and adults; the major vaccine platforms and how they elicit protection; the contraindications and adverse events that bound safe use; and the special considerations for populations such as pregnant people, the immunocompromised, and travellers. It frames vaccination as population and clinical prevention; it is reference and educational material, not an immunization prescription for any individual.
Sub-topics
Core questions
- How does a vaccine convert exposure to an antigen into durable protection against disease?
- How are immunization schedules constructed across the life course, and why are doses timed and spaced as they are?
- Beyond protecting the vaccinated individual, how does immunization reduce transmission and confer herd (community) immunity?
- What are the genuine contraindications to vaccination, and how are adverse events detected and distinguished from coincidental illness?
- How does immunization practice adapt for special populations such as pregnant people, the immunocompromised, and older adults?
Key concepts
- Active versus passive immunization
- Antigen, adjuvant, and the adaptive immune response
- Immunologic memory and durability of protection
- Correlates of protection
- Herd (community) immunity and the herd-immunity threshold
- Vaccine efficacy versus effectiveness
- Immunization schedule and catch-up vaccination
- Contraindications, precautions, and adverse events following immunization
- Vaccine confidence and hesitancy
Mechanisms
A vaccine presents the immune system with antigens derived from or resembling a pathogen, together in many cases with an adjuvant that amplifies the innate response. This primes antigen-specific B and T lymphocytes and generates long-lived memory cells, so that on later exposure to the real pathogen the recipient mounts a faster and stronger response that prevents or attenuates disease (Plotkin, 2010). The measurable immune marker associated with protection is termed a correlate of protection, which underpins schedule design and licensure (Plotkin, 2010). At the population level, by reducing the number of susceptible hosts, immunization lowers the effective reproduction number of a pathogen and can confer indirect protection on the unvaccinated once coverage exceeds the herd-immunity threshold (Fine, 2011).
Clinical relevance
Immunization is a core component of preventive care delivered in primary care, paediatrics, occupational health, and public-health programmes, and clinicians routinely assess immunization status, recommend indicated vaccines, and counsel on benefits and risks. Andre and colleagues (2008) summarise the large reductions in disease, disability and death attributable to vaccination worldwide. This entry describes how immunization works and how it is organised as preventive practice; specific schedules, eligibility, and contraindications for an individual are governed by current national recommendations and clinical judgement and are not provided here.
Epidemiology
Vaccine-preventable diseases account for a substantial share of historical infectious-disease morbidity and mortality, and immunization programmes have driven steep declines in incidence and, for smallpox, eradication (Andre, 2008). Sustained high coverage is required to maintain herd immunity; falling or unevenly distributed coverage has been linked to the re-emergence of diseases such as measles, and erosion of vaccine confidence is recognised as a threat to programme performance (Larson, 2011; Fine, 2011).
History
Active immunization traces from Edward Jenner's late-eighteenth-century cowpox inoculation against smallpox through Pasteur's attenuated vaccines to the twentieth-century development of vaccines against diphtheria, pertussis, tetanus, polio, measles and many other pathogens. The global smallpox eradication campaign, certified in 1980, remains the defining achievement of organised immunization, and modern programmes have since extended protection across the life course (Andre, 2008).
Debates
- How should programmes respond to vaccine hesitancy and the erosion of confidence?
- Maintaining the high coverage needed for herd immunity depends on public trust; declining confidence in some settings has been associated with outbreaks of previously controlled diseases, making communication and confidence-building a central programmatic challenge rather than a purely technical one.
Key figures
- Stanley A. Plotkin
- Walter A. Orenstein
- Paul Fine
- Heidi J. Larson
- Bali Pulendran
Related topics
Seminal works
- andre-2008
- plotkin-2010
- fine-2011
- plotkin-orenstein-2018
Frequently asked questions
- What is the difference between active and passive immunization?
- Active immunization (vaccination) stimulates the recipient's own immune system to build protection and immunologic memory, typically giving long-lasting protection. Passive immunization gives ready-made antibodies (for example immunoglobulin), providing immediate but temporary protection without inducing memory.
- What does herd immunity mean?
- Herd, or community, immunity is the indirect protection of susceptible people that arises when a sufficiently high proportion of a population is immune, so that the pathogen can no longer spread efficiently. The coverage needed depends on how transmissible the pathogen is (Fine, 2011).